Despite significant consumer and scientific interest, the NAD Enhancer Market faces several challenges that influence clinical credibility, regulatory positioning, and market expansion. One of the primary restraints is the limited human clinical evidence demonstrating durable efficacy for specific health outcomes beyond biomarker changes. While NAD+ levels can be increased by precursor...